4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000041
Director sold 6,000 shares at $385.08 ($2,310,481)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nusse Roeland · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-08 | Exercise or conversion : show line 1 in the form | +1,000 | $70.35 | $70,350 | 7,765 | D |
| 2021-02-08 | Exercise or conversion : show line 2 in the form | +5,000 | $66.90 | $334,500 | 12,765 | D |
| 2021-02-08 | Sale : show line 3 in the form | −6,000 | $385.08 | $2,310,481 | 6,765 | D |
| Open-market sales · 6,000 sh · avg $385.08 · $2,310,481 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-08 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −1,000 | 4,000 | D |
| 2021-02-08 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −5,000 | 0 | D |
Loading xslF345X03/edgar.xml…